A detailed history of Swisspartners Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Swisspartners Ltd. holds 10,293 shares of MRK stock, worth $1.17 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
10,293
Previous 4,390 134.46%
Holding current value
$1.17 Million
Previous $378,000 201.85%
% of portfolio
1.46%
Previous 0.39%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $516,158 - $661,785
5,903 Added 134.46%
10,293 $1.14 Million
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $58,443 - $66,248
-700 Reduced 13.75%
4,390 $413,000
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $190,023 - $213,004
2,585 Added 103.19%
5,090 $417,000
Q1 2022

May 04, 2022

SELL
$73.51 - $82.4 $190,023 - $213,004
-2,585 Reduced 50.79%
2,505 $214,000
Q3 2021

Nov 16, 2021

BUY
$71.68 - $78.83 $364,851 - $401,244
5,090 New
5,090 $382,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Swisspartners Ltd. Portfolio

Follow Swisspartners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swisspartners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Swisspartners Ltd. with notifications on news.